High apoptotic activity and low epithelial cell proliferation with underexpression of p21WAF1/CIP1 and p27Kip1 of mucinous carcinomas of the colorectum -: Comparison with well-differentiated type

被引:18
作者
Akino, F
Mitomi, H
Nakamura, T
Ohtani, Y
Ichinoe, M
Okayasu, I
机构
[1] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 2288555, Japan
关键词
colorectal neoplasm; mucinous carcinoma; apoptosis; cell cycle; p21(WAF1/CIP1); P27(Kip1); immunohistochemistry c-Ki-ras;
D O I
10.1309/D4QM-379U-E8J2-9R1M
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We comparatively assessed 41 mucinous colorectal carcinomas (MUCs) and 620 non-MUC (well-, moderately, and poorly differentiated adenocarcinoma) cases for clinicopathologic findings; and 41 MUCs and 115 randomly selected non-MUCs also were studied for the following: (1) apoptotic activity and Ki-67 immunoreactivity: (2) immunohistochemical expression of p21(WAF1/CIP1), p27(Kip1), p53, and bcl-2; and (3) c-Ki-ras mutations. The rates for lymph node involvement and peritoneal dissemination were higher in MUCs than in non-MUCs. Multivariate analysis showed MUCs to have a worse prognosis than well-differentiated adenocarcinomas. The Ki-67 labeling,for MUCs was Significantly lower than that for non-MUCs, whereas the apoptotic index was significantly higher than for the well-differentiated type. The labeling for p21(WAF1/CIP1) and p27(Kip1) was lower in MUCs (2.7% and 35.3%, respectively) than in well-differentiated adenocarcinomas (4.2% and 48.6%, respectively). MUCs can be considered a different tumor from the well-differentiated type, with a poor prognosis owing to frequently lymph node metastasis and peritoneal dissemination, and characterized by, high apoptotic and low proliferative activities associated with low p21(WAF1/CIP1) and p27(Kip1) expression.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 41 条
  • [1] INSITU END-LABELING DETECTS DNA STRAND BREAKS IN APOPTOSIS AND OTHER PHYSIOLOGICAL AND PATHOLOGICAL STATES
    ANSARI, B
    COATES, PJ
    GREENSTEIN, BD
    HALL, PA
    [J]. JOURNAL OF PATHOLOGY, 1993, 170 (01) : 1 - 8
  • [2] CAMPO E, 1991, CANCER RES, V51, P4436
  • [3] Ciaparrone M, 1998, CANCER RES, V58, P114
  • [4] Cell cycle and cancer: Critical events at the G1 restriction point
    DelSal, G
    Loda, M
    Pagano, M
    [J]. CRITICAL REVIEWS IN ONCOGENESIS, 1996, 7 (1-2): : 127 - 142
  • [5] Doglioni C, 1996, J PATHOL, V179, P248, DOI 10.1002/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO
  • [6] 2-6
  • [7] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [8] ENOMOTO T, 1991, AM J PATHOL, V139, P777
  • [9] A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS
    FEARON, ER
    VOGELSTEIN, B
    [J]. CELL, 1990, 61 (05) : 759 - 767
  • [10] Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis
    Frankfurt, OS
    Robe, JA
    Sugarbaker, EV
    Villa, L
    [J]. EXPERIMENTAL CELL RESEARCH, 1996, 226 (02) : 387 - 397